- •Foreword
- •Preface
- •Contributors
- •Reference
- •2 Evaluation of the Cosmetic Patient
- •The Eightfold Path to Patient Happiness
- •Listen to Your Patient Before Surgery (or you will surely have to listen to them after)
- •Document and Demonstrate
- •Ensure Appropriate Patient Motivation
- •Determine Realistic Surgical Goals
- •Conduct a Thorough Informed Consent
- •Create an Aesthetic Environment
- •Topical Ocular Anesthetics
- •Lidocaine
- •Bupivacaine
- •Epinephrine
- •EMLA
- •Other Topical Anesthetics
- •Bicarbonate
- •Benzyl Alcohol
- •References
- •Facial Nerve Blocks
- •Retrobulbar and Peribulbar Blocks
- •References
- •Sensory Nerve Blocks
- •Lacrimal Nerve Block
- •Frontal Nerve Block
- •Nasociliary Nerve Block
- •Infraorbital Nerve Block
- •Zygomaticofacial Nerve Block
- •Staff
- •Monitoring
- •Minimal Sedation
- •Moderate Sedation
- •Antagonists/Reversal Agents
- •References
- •Selection of Local Anesthesia
- •Selection of Oral Sedative Agent
- •Procedure
- •References
- •19 Keys to Success When Marking the Skin in Upper Blepharoplasty
- •26 Blepharoplasty Incisional Modalities: 4.0 Radiowave Surgery vs. CO2 Laser
- •Study
- •Results
- •References
- •27 Fat Preservation and Other Tips for Upper Blepharoplasty
- •28 Asian Blepharoplasty
- •29 Internal Brow Elevation with Corrugator Removal
- •41 Three-Step Technique for Lower Lid Blepharoplasty
- •Step 1: Transconjunctival Fat Removal
- •Step 3: Resuspension of the Anterior Lamella and Adjacent Malar Fat Pad to the Lateral Orbital Periosteum
- •Rationale for the Three-Step Procedure
- •Pearls
- •References
- •Divide Each Fat Pad Flush with the Orbital Rim—Nasal and Central Fat Pads
- •Divide Each Fat Pad Flush with the Orbital Rim—Lateral Fat Pad
- •Surgical Technique
- •Postoperative Care
- •Complications
- •Comments
- •References
- •54 Transconjunctival Lower Blepharoplasty with Intra-SOOF Fat Repositioning
- •Patient Selection
- •Procedure
- •Postoperative
- •Conclusion
- •References
- •56 Use of Tisseel in Lower Eyelid Blepharoplasty with Fat Repositioning
- •57 Lower Blepharoplasty with Fat Repositioning Without Sutures
- •Fat-Repositioning Procedure
- •References
- •Indications
- •Complications
- •Procedure
- •Stage 1
- •Stage 2
- •Conclusions
- •References
- •61 Treatment of Postblepharoplasty Lower Eyelid Retraction with Dermis Fat Spacer Grafting
- •Surgical Technique
- •References
- •Tumescent Technique
- •Avoiding Anesthetic Toxicity
- •Tumescent Technique
- •References
- •69 Incision Technique for Endoscopic Forehead Elevation
- •Central Incision
- •Paracentral Incisions
- •Temporal Incisions
- •Prevention of Alopecia
- •71 Endoscopic Midforehead Techniques: Improved Outcomes with Decreased Operative Time and Cost
- •Suggested Reading
- •Dissection of Central Forehead Space and Scalp
- •Dissection of Temporal Space
- •Release of Periosteum
- •77 Endosocopic Browlift with Deep Temporal Fixation Only*
- •Endoscopic Browlift with Deep Temporal Fixation Only
- •Temporal Lift
- •Surgical Technique
- •Incisions
- •Release of the Brow Depressor Muscles
- •Brow Elevation and Fixation
- •Results (Before and After Photographs)
- •Introduction
- •Surgical Technique
- •Conclusions
- •References
- •79 Scalp Fixation in Endoscopic Browlift
- •Suggested Reading
- •82 The Direct Browlift: Focus on the Tail
- •Patient Selection
- •Procedure
- •Postoperative
- •Complications
- •Conclusion
- •Introduction
- •Procedure
- •Conclusions
- •References
- •86 The Subperiosteal Mid-Face Lift Using Bioabsorbable Implants for Fixation*
- •References
- •88 Mid-Face Implants
- •105 Shaping of the Eyebrows with Botox
- •Modifying the Position of the Medial Eyebrows
- •Modifying the Position of the Lateral Eyebrows
- •Arching and Lifting the Eyebrows
- •Lowering and Flattening the Eyebrows
- •Treating Eyebrow Asymmetry
- •Pitfalls
- •Conclusion
- •References
- •109 Botox Injection to the Lacrimal Gland for the Treatment of Epiphora
- •113 Optimizing Outcome from Facial Cosmetic Injections and Promoting Realistic Expectations
- •Preparations
- •Posttreatment
- •Expectations
- •115 List of Fillers
- •Consultation
- •Anesthesia
- •Choice of Filler
- •Anatomic Guidelines
- •Technique
- •Summary
- •References
- •121 Liquid Injectable Silicone for the Upper Third of the Face
- •References
- •122 Periocular Injectables with Hyaluronic Acid and Calcium Hydroxyapatite
- •General Principles
- •Hyaluronic Acid (HA)
- •Calcium Hydroxyapatite
- •References
- •125 Pearls for Periorbital Fat Transfer
- •129 Retinoids for the Cosmetic Patient
- •Background
- •Suggested Reading
- •Patient Selection
- •Infrared vs. Pulsed Dye
- •Postoperative Care
- •Choosing a Device
- •KTP or Frequency-Doubled Nd:YAG laser (532 nm)
- •Pulsed-Dye Laser (585 nm, 595 nm)
- •Intense-Pulsed Light Device (500–1200 nm)
- •Long-Pulsed Nd:YAG laser (1064 nm)
- •Fractional Resurfacing Lasers
- •Low Intensity Sources
- •Laser and Light Sources for Skin Rejuvenation
- •Patient Evaluation
- •Surgical Planning
- •Anesthetic Techniques
- •Surgical Procedure
- •Postoperative Care
- •Background
- •Technology
- •Patient Selection
- •Treatment
- •Conclusion
- •Key Elements of Procedure
- •Patient Selection and Preparation
- •Procedure
- •Postoperative
- •Conclusion
- •References
- •145 Repair of the Torn Earlobe
- •Questions to Ask the Patient
- •Basic Principles
- •Surgical Technique for Complete Earlobe Tears
- •Surgical Repair for Partial Torn Earlobes
- •References
- •Introduction
- •Preoperative Markings
- •Technique
- •Discussion
- •Conclusion
- •Reference
- •147 SMAS Malar Fat Pad Lift with Short Scar Face Lift
- •148 Ten Tips for a Reliable and Predictable Deep Plane Facial Rhytidectomy
- •Introduction
- •Tip 1. Marking (Figure 148.1)
- •Tip 2. Skin Flap Dissection (Figure 148.2)
- •Tip 3. Marking the Zygomatic Arch (Figure 148.3)
- •Tip 4. SMAS Flap Creation (Figure 148.4)
- •Tip 5. Creating the SMAS Flap (Figure 148.5 and 148.6)
- •Tip 6. SMAS Flap Fixation (Figure 148.7)
- •Tip 7. Skin Flap Fixation (Figure 148.8)
- •Tip 8. Addressing the Earlobe (Figure 148.9)
- •Tip 9. Skin Excision Tips (Figure 148.10)
- •Tip 10. Addressing the Neck (Figure 148.11)
- •References
- •153 Adjustable Suture Technique for Levator Surgery
- •Surgical Technique
- •Reference
- •154 Tarsal Switch Levator Resection for the Treatment of Myopathic Blepharoptosis
- •Surgical Technique
- •Suggested Reading
- •156 Minimally Invasive Ptosis Repair
- •Mini-invasive Ptosis Surgery
- •Suggested Reading
- •Further Reading
- •158 Ptosis Repair by a Single-Stitch Levator Advancement
- •Reference
- •References
- •171 Medial Canthorraphy
- •Index
115
List of Fillers
Bradley T. Kovach
345
Table 115.1. List of fillers
Category |
Trade name |
Composition |
Year of |
FDA–approved |
|
(company) |
|
FDA |
indications (year of |
|
|
|
approval |
approval) |
Superficial dermal fillers |
|
|
|
|
|
Cosmoderm I |
Human collagen 35 mg/ml |
2003 |
Injection into the |
|
(Allergan) |
in 0.3% lidocaine |
|
superficial papillary |
|
|
|
|
dermis for correction of |
|
|
|
|
soft tissue contour |
|
|
|
|
deficiencies such as |
|
|
|
|
wrinkles and acne scars |
|
Cosmoderm II |
Human collagen 65 mg/ml |
2005 |
Same as Cosmoderm I |
|
(Allergan) |
in 0.3% lidocaine |
|
|
|
Zyderm I |
Bovine collagen 35 mg/ml |
1981 |
Same as Cosmoderm I |
|
(Allergan) |
in 0.3% lidocaine |
|
|
|
Zyderm II |
Bovine collagen 65 mg/ml |
1983 |
Same as Cosmoderm I |
|
(Allergan) |
in 0.3% lidocaine |
|
|
Midand deep dermal fillers |
|
|
|
|
|
Cosmoplast |
Human collagen 35 mg/ml |
2003 |
Injection in the midto |
|
(Allergan) |
crosslinked with |
|
deep dermis for |
|
|
glutaraldehye in 0.3% |
|
correction of soft tissue |
|
|
lidocaine |
|
contour deficiencies |
|
|
|
|
such as wrinkles and |
|
|
|
|
acne scars |
|
Captique |
Hyaluronic acid 5.5 mg/ml |
2004 |
Injection in the midand |
|
(Allergan) |
|
|
deep dermis for |
|
|
|
|
correction of moderate |
|
|
|
|
to severe facial |
|
|
|
|
wrinkles and folds |
|
|
|
|
(such as the nasolabial |
|
|
|
|
folds) |
Additional clinical uses
Overlay of deeper
fillers
Same as
Cosmoderm I
Same as
Cosmoderm I
Same as
Cosmoderm I
Lip augmentation, folds (such as nasolabial folds and marionette lines), angles of the mouth
Lip augmentation, marionette lines, tear troughs, angles of the mouth, prejowl sulcus, atrophic scars, others
Duration of
effect
2–4 months
2–4 months 2–4 months 2–4 months
3–5 months
3–5 months
continued
Fillers of List 115 Chapter
347
Table 115.1. Continued
Category |
Trade name |
Composition |
Year of |
FDA–approved |
|
(company) |
|
FDA |
indications (year of |
|
|
|
approval |
approval) |
|
Elevess |
Hyaluronic acid 28 mg/ml |
2006 |
Same as Captique |
|
(Galderma |
with 0.3% lidocaine |
|
|
|
Phama. S.a., |
|
|
|
|
and Anika |
|
|
|
|
Therapeutics) |
|
|
|
|
Augmentation |
|
|
|
|
Product |
|
|
|
|
(Anika |
|
|
|
|
Therapeutics, |
|
|
|
|
Inc.) |
|
|
|
|
Fascian (Fascia |
Freeze-dried cadaveric |
FDA |
FDA approval not |
|
Biosystems, |
fascia lata reconstituted |
approval |
required |
|
LLC) |
with saline or lidocaine |
not |
|
|
|
|
required |
|
|
Hylaform |
Hyaluronic acid 5.5 mg/ml |
2004 |
Same as Captique |
|
(Allergan) |
|
|
|
|
Juvederm Ultra |
Hyaluronic acid 24 mg/ml |
2006 |
Same as Captique |
|
(Allergan) |
|
|
|
|
Restylane |
Hyaluronic acid 20 mg/ml |
2003 |
Same as Captique |
|
(Medicis) |
|
|
|
|
Zyplast |
Bovine collagen 35 mg/ml |
1985 |
Same as Cosmoplast |
|
(Allergan) |
crosslinked with |
|
|
|
|
glutaraldehye in 0.3% |
|
|
|
|
lidocaine |
|
|
Deep dermal fillers |
|
|
|
|
|
Hylaform Plus |
Hyaluronic acid 5.5 mg/ml |
2004 |
Same as Captique |
|
(Allergan) |
|
|
|
Additional clinical |
Duration of |
uses |
effect |
Not commercially |
Approximately |
available |
6 months |
Lip augmentation, |
Not well |
rhytids and folds, |
known (at |
atrophic scars |
least 3–4 |
|
months) |
Same as Captique |
3–5 months |
Same as Captique |
6–12 months |
Same as Captique |
5–7 months |
Same as Cosmoplast |
3–5 months |
Marionette lines, |
3–5 months |
angles of the |
|
mouth atrophic |
|
scars, prejowl |
|
sulcus |
|
hovacK .T.B 348
Juvederm Ultra |
Hyaluronic acid 24 mg/ml |
2006 |
Same as Captique |
Plus |
|
|
|
(Allergan) |
Calcium hydroxyapatite |
|
|
Radiesse |
2006 (for |
Subdermal implantation |
|
(Bioform |
microspheres |
cosmetic |
for correction of |
Medical, Inc.) |
|
use) |
moderate to severe |
|
|
|
facial wrinkles and |
|
|
|
folds, such as the |
|
|
|
nasolabial folds; |
|
|
|
subdermal implantation |
|
|
|
for correction of |
|
|
|
HIV-associated |
|
|
|
lipoatrophy; oral/ |
|
|
|
maxillofacial defects; |
|
|
|
vocal cord insufficiency; |
|
|
|
radiographic tissue |
|
|
|
marking |
Subcutaneous fillers |
|
|
|
AdatoSil-5000 |
Liquid injectable silicone |
1994 |
Prolonged retinal |
(Bausch and |
|
|
tamponade in |
Lomb) |
|
|
complicated retinal |
|
Polymethylmethacrylate |
|
detachments |
Artefill (Artes |
2006 |
Correction of the |
|
Medical, Inc) |
microspheres in vehicle |
|
nasolabial folds |
|
of 3.5% bovine collagen |
|
|
|
with 0.3% lidocaine |
|
|
Autologous fat |
Autologous fat |
FDA |
FDA approval not |
|
|
approval |
required |
|
|
not |
|
|
|
required |
|
Same as Hylaform |
6–12 months |
Plus |
|
Cutaneous lip |
9–18 months |
augmentation (not |
|
vermillion lip), |
|
age-related |
|
lipoatrophy, facial |
|
contouring, |
|
atrophic scars |
|
Moderate to severe |
Permanent |
rhytids and folds, |
|
atrophic scars |
|
Moderate to severe |
Permanent |
rhytids and folds, |
|
atrophic scars |
|
Lip augmentation, |
1 year– |
facial folds, facial |
permanent |
contouring, |
|
lipoatrophy, dorsal |
|
hand |
|
augmentation, |
|
correction of |
|
liposuction |
|
contour defects |
continued |
|
Fillers of List 115 Chapter
349
Table 115.1. Continued
Category |
Trade name |
Composition |
Year of |
FDA–approved |
|
(company) |
|
FDA |
indications (year of |
|
|
|
approval |
approval) |
|
Cymetra (Life |
Human cadaveric proteins, |
FDA |
FDA approval not |
|
Cell |
primarily collagen, |
approval |
required (classified as |
|
Corporation) |
elastin, and |
not |
banked human tissue) |
|
|
glycosaminoglycans |
required |
|
|
|
|
(classified |
|
|
|
|
as banked |
|
|
|
|
human |
|
|
Sculptra (Dermik Poly-L-lactic acid particles |
tissue) |
|
|
|
2004 |
HIV-associated facial |
||
|
Laboratories) |
2–50 m in diameter |
|
lipoatrophy |
|
|
reconstituted with 2– |
|
|
|
|
10 ml saline or lidocaine |
|
|
|
Silikon-1000 |
Liquid injectable silicone |
1997 |
Same as AdatoSil-5000 |
|
(Alcon) |
|
|
|
Subdermal implants |
|
|
|
|
|
Advanta |
Expanded |
2000 |
Facial plastic and |
|
(Oceanbreeze |
polytetrafluoroethylene |
|
reconstructive surgery |
|
Surgical |
|
|
|
|
Supply) |
|
|
FDA approval not |
|
Alloderm (Life |
Human cadaveric proteins, |
FDA |
|
|
Cell |
primarily collagen, |
approval |
required (classified as |
|
Corporation) |
elastin, and |
not |
banked human tissue) |
|
|
glycosaminoglycans |
required |
|
|
|
|
(classified |
|
|
|
|
as banked |
|
human tissue)
hovacK .T.B 053
Additional clinical |
Duration of |
uses |
effect |
Lip augmentation, |
3–6 months |
deep rhytids and |
|
folds, atrophic |
|
scars |
|
Age-related |
Up to 2 years |
lipoatrophy, facial |
|
contouring |
|
Moderate to severe |
Permanent |
rhytids and folds, |
|
atrophic scars |
|
Lip augmentation, |
Permanent |
deep rhytids and |
|
folds |
|
Same as Advanta |
6–12 months |
Softform (Tissue |
Expanded |
1998 |
Plastic and reconstructive |
Same as Advanta |
Permanent |
Technologies, |
polytetrafluoroethylene |
|
surgery |
|
|
Inc.) |
|
|
|
|
|
Ultrasoft (Tissue Expanded |
2001 |
Plastic and reconstructive |
Same as Advanta |
Permanent |
|
Technologies, |
polytetrafluoroethylene |
|
surgery |
|
|
Inc.) |
|
|
|
|
|
Fillers of List 115 Chapter
351
116
Dermal Filler Pearls:
the Hyaluronic Acids
John R. Burroughs and Richard L. Anderson
Our preferred hyaluronic acid dermal fillers are Restylane, Perlane, and
Juvederm. Each of these has a very high safety profile and are easier to inject than Radiesse. They are outstanding for lip enhancement, including the vermillion border, perioral rhytids, and for less severe glabellar and nasolabial folds or as a superficial fine tuning to deeper filling with Radiesse. The newer, higher viscosity hyaluronic acids, however, are excellent for deep lip augmentation, nasolabial folds, and deep rhytid
lling.We have found excellent success treating nasojugal (“tear trough”) deformities with hyaluronic acids, which offers a nonsurgical option to cosmetic lower eyelid blepharoplasty (Figure 116.1). Patients require variable amounts depending on the desired outcome and severity of the folds. Injections deep (periosteally) or just below the orbicularis tend to cause less swelling and bruising below the eyes. The effects are potentiated by the concomitant application of Botox. We generally use the provided needle and find that direct injection with withdrawal of the needle as well as the described “feathering” technique both work well.
We routinely perform the infraorbital and mental nerve blocks as previously prescribed, as lip injections are quite painful. Premark the perioral rhytids prior to the nerve blocks to ensure optimal filling.
We have found that the hyaluronic acids last longer when Botox is also injected. We recommend that patients not aggressively massage any perceived irregularities, as this can worsen bruising and swelling and the patient may inadvertently overmassage the filler out of position. We advise patients to ice the areas a few hours following injections to reduce swelling. Injection to areas of high dynamicity (the perioral rhytids) will last less time that relatively adynamic areas, such as horizontal forehead rhytids or lower eyelid tear trough defects. Perlane and Juvederm Ultra Plus contain higher concentrations and reportedly last longer than the other hyaluronic formulations. Deep rhytids may further benefit by first performing subcision with a needle (e.g., 27-gauge) followed by placement of hyaluronic filler.
352
Chapter 116 Dermal Filler Pearls: the Hyaluronic Acids 353
A
B
Figure 116.1. (A) Preinjection of Restylane in a patient with pronounced lower eyelid hollowness “tear trough deformities.” (B) Immediately following the injections, showing the marked improvement.
117
Radiesse Pearls
John R. Burroughs and Richard L. Anderson
For deep glabellar and nasolabial folds, our preferred filler is Radiesse® Radiesse is calcium hydroxyapatite gel. Radiesse is an excellent dermal ller for severe folds, wrinkles that require large volumes and respond well to deep placement, which is critical with Radiesse. It is recommended to inject Radiesse below the dermis to avoid visibly noticeable lumps and irregularities. For the nasolabial folds, inject slightly medial to each nasolabial fold as the natural muscular action of the facial muscles will tend to lateralize the effect and can worsen the appearance of the
folds if not placed medially (Figure 117.1).
We inject with a 1.25-inch 27-gauge needle as the material is quite thick. A linear threading or fanning technique can be used to achieve linear filling or volumization. Mark the nasolabial folds prior to injection of a nerve block, which is preferred by most patients for nasolabial and lip augmentation. The nerve block is performed by injecting the upper and lower gingival sulcus with a 1.25-inch 27-gauge needle in line with the patient’s pupils, which will anesthetize the infraorbital and mental nerves. Use 1–2% lidocaine with epinephrine with 1–2 ml at each injection site. It is critical to premark the nasolabial folds prior to local anesthetic injection due to distortion of the tissues and to ensure slight medialization of the fi ller placement. A single syringe (1.3 cc) of Radiesse is adequate for most nasolabial folds. Some patients desire or require a second syringe at a later time to achieve an optimal result. In the glabellar areas a quarter to half a syringe is all that is required. Patients should be cautioned, and placement must be precise in the glabellar region as necrosis and or visual loss has been reported with intravascular injection of llers. In general, glabellar fold injections are not uncomfortable, and we do not inject local anesthetic, which distorts the target area. However, a small amoung (0.5 cc) of local may be injected for supratrochlear and suproorbital nerve blocks.Radiesse is not optimal for lip augmentation, as the patients often complain of lumps and irregularities. Caution must be exercised to avoid injecting Radiesse too superficially, which can cause skin necrosis. We have found Radiesse to give improvement for the reported 2 years in most of our patients.
354
Chapter 117 Radiesse Pearls 355
Figure 117.1. Injection of Radiesse into the left nasolabial fold. Note the slight medial placement to the premarked nasolabial fold.
118
Juvederm Pearls: Fine and
Superficial Lines
John R. Burroughs and Richard L. Anderson
Juvederm is a newer nonanimal-based hyaluronic acid that has the advantage of lower viscosity allowing for easier injection. Juvederm is technically for filling minimal rhytids, particularly for perioral lines and for defining the vermillion border. It works very well to enhance the vermillion border as an adjunct to deeper lip augmentation with Restylane, Perlane, and Juvederm Ultra Plus. Superficial, fine lines may also be treated by fi rst performingsubcision with an injection needle (e. g., 27-gauge), followed by an injection of hyaluronic acid through a 32guage needle. The 32-gauge needle seems to thin the filler viscosity, enabling fine, super cial rhytid filling while avoiding lumps. Caution is needed with superficial filling to avoid skin color discoloration, and it is imperative to ensure that the needle is securely fastened to the luer-lock syringe to avoid accidental needle expulsion and potential ocular injury.1
Reference
1.Lin DJ, Sami MS, Burroughs JR, Soparkar CN, Patrinely JR. Ocular injury from local anesthetic injections: needle expulsion—the luer-lock allure. Arch Facial Plast Surg 2006;8:436.
356
